| |
Tamoxifen previously had been shown to reduce the risk of estrogen receptor (ER) positive breast cancer in women at high risk of the disease, but not to affect the chance of developing ER-negative disease. For the study, 13,388 women at high risk of breast cancer participated in the trial; 174 women were diagnosed with ER-positive tumors and 69 women with ER-negative tumors. "These data suggest that 5-a reductase inhibitors do not confer a negative risk for bone health and, in fact, may lower the risk of hip fracture. pills from hoodia plant; balena allegra camping;
Dr. The study was presented at an American College of Gastroenterology conference. And the U.S. benifits of cla; one week enough diflucan for candida;
|
|
- 08/10/14(火) 10:33 -
